Prognostic value of interim fluorodeoxyglucose and fluorothymidine PET/CT in diffuse large B-cell lymphoma
- PMID: 30004787
- PMCID: PMC6475957
- DOI: 10.1259/bjr.20180240
Prognostic value of interim fluorodeoxyglucose and fluorothymidine PET/CT in diffuse large B-cell lymphoma
Abstract
Objective:: To examine the prognostic value of fluorodeoxyglucose (FDG) and fluorothymidine (FLT) interim positron emission tomography/CT (PET/CT) for diffuse large B-cell lymphoma (DLBCL).
Methods:: 44 patients with newly diagnosed DLBCL underwent both fluorine 18 FDG (18F-FDG) and 18F-FLT PET/CT scans at baseline and after two cycles of a rituximab-containing chemotherapy regimen. Maximum standard uptake values (SUVmax) and changes in SUV (ΔSUV) were calculated for both tracers for the predominant lesion of each patient, for prediction of progression-free survival (PFS) and overall survival (OS).
Results:: The median follow-up period was 71 months. Receiver operating characteristic (ROC) analysis indicated that the best ΔSUV cut-off values for FDG (ΔSUVFDG) and FLT (ΔSUVFLT) were 79 and 76%, respectively. A ΔSUVFLT cut-off of 76% had the highest significance for prediction of PFS (p = 0.003) and OS (p = 0009), with sensitivity, specificity, and accuracy of 80.0, 85.7, and 81.8% respectively in response assessment.
Conclusion:: Interim FLT PET/CT had higher specificity and accuracy than standard FDG PET/CT-based interpretation.
Advances in knowledge:: This study demonstrated that interim FLT PET/CT had higher accuracy than standardized FDG-based interpretation for therapeutic response assessment in DLBCL. FLT had the advantage of potentially reducing false positive of interim FDG PET/CT.
Conflict of interest statement
Figures



Similar articles
-
Diffuse Large B-Cell Lymphoma: Prospective Multicenter Comparison of Early Interim FLT PET/CT versus FDG PET/CT with IHP, EORTC, Deauville, and PERCIST Criteria for Early Therapeutic Monitoring.Radiology. 2016 Jul;280(1):220-9. doi: 10.1148/radiol.2015150689. Epub 2016 Feb 8. Radiology. 2016. PMID: 26854705 Free PMC article.
-
Prognostic analysis of interim 18F-FDG PET/CT in patients with diffuse large B cell lymphoma after one cycle versus two cycles of chemotherapy.Eur J Nucl Med Mol Imaging. 2019 Feb;46(2):478-488. doi: 10.1007/s00259-018-4198-6. Epub 2018 Oct 31. Eur J Nucl Med Mol Imaging. 2019. PMID: 30382301 Free PMC article.
-
[Prognostic Value of Interim PET/CT in 227 Patients of DLBCL].Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2019 Feb;27(1):74-79. doi: 10.7534/j.issn.1009-2137.2019.01.012. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2019. PMID: 30738450 Chinese.
-
Predictive value of F-18 FDG PET/CT quantization parameters in diffuse large B cell lymphoma: a meta-analysis with 702 participants.Med Oncol. 2015 Jan;32(1):446. doi: 10.1007/s12032-014-0446-1. Epub 2014 Dec 16. Med Oncol. 2015. PMID: 25511321
-
End-of-Treatment PET/Computed Tomography Response in Diffuse Large B-Cell Lymphoma.PET Clin. 2019 Jul;14(3):307-315. doi: 10.1016/j.cpet.2019.03.001. PET Clin. 2019. PMID: 31084771 Review.
Cited by
-
The value of FDG PET/CT imaging in outcome prediction and response assessment of lymphoma patients treated with immunotherapy: a meta-analysis and systematic review.Eur J Nucl Med Mol Imaging. 2022 Nov;49(13):4661-4676. doi: 10.1007/s00259-022-05918-2. Epub 2022 Aug 6. Eur J Nucl Med Mol Imaging. 2022. PMID: 35932329 Free PMC article.
-
Emerging Role of [18F]FLT PET/CT in Lymphoid Malignancies: A Review of Clinical Results.Hematol Rep. 2024 Jan 11;16(1):32-41. doi: 10.3390/hematolrep16010004. Hematol Rep. 2024. PMID: 38247994 Free PMC article. Review.
-
The Role of 11C-Methionine PET Imaging for the Evaluation of Lymphomas: A Systematic Review.Hematol Rep. 2024 Nov 27;16(4):752-768. doi: 10.3390/hematolrep16040072. Hematol Rep. 2024. PMID: 39728002 Free PMC article. Review.
-
Remaining challenges in predicting patient outcomes for diffuse large B-cell lymphoma.Expert Rev Hematol. 2019 Nov;12(11):959-973. doi: 10.1080/17474086.2019.1660159. Epub 2019 Sep 12. Expert Rev Hematol. 2019. PMID: 31513757 Free PMC article. Review.
-
Radiographic findings useful for diagnosis of primary chest wall lymphoma without preceding pleural disease: A case report.Respirol Case Rep. 2022 Aug 15;10(9):e01019. doi: 10.1002/rcr2.1019. eCollection 2022 Sep. Respirol Case Rep. 2022. PMID: 35992553 Free PMC article.
References
-
- Miyazaki Y, Nawa Y, Miyagawa M, Kohashi S, Nakase K, Yasukawa M, et al. . Maximum standard uptake value of 18F-fluorodeoxyglucose positron emission tomography is a prognostic factor for progression-free survival of newly diagnosed patients with diffuse large B cell lymphoma. Ann Hematol 2013; 92: 239–44. doi: 10.1007/s00277-012-1602-3 - DOI - PMC - PubMed
-
- Akkas BE, Vural GU. Standardized uptake value for (18)F-fluorodeoxyglucose is correlated with a high International Prognostic Index and the presence of extranodal involvement in patients with diffuse large B-cell lymphoma. Rev Esp Med Nucl Imagen Mol 2014; 33: 148–52. doi: 10.1016/j.remn.2013.07.008 - DOI - PubMed
-
- Itti E, Meignan M, Berriolo-Riedinger A, Biggi A, Cashen AF, Véra P, et al. . An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax. Eur J Nucl Med Mol Imaging 2013; 40: 1312–20. doi: 10.1007/s00259-013-2435-6 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources